Understanding how RNA Polymerase II helps in gene transcription
Mechanisms of RNA Polymerase II transcription
This study is exploring how a key enzyme called RNA Polymerase II helps turn genes on and off in yeast cells, which could help us understand more about how our genes work and are controlled.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11000822 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which RNA Polymerase II (Pol II) transcribes genes in eukaryotic cells, focusing on the processes of initiation and elongation. By using the model organism Saccharomyces cerevisiae, the study aims to identify the factors that influence the selection of transcription start sites and how Pol II activity affects these processes. The research employs advanced techniques such as massively parallel promoter assays and genome-wide analysis to uncover the connections between Pol II elongation and RNA processing events like splicing. This work could provide insights into the fundamental processes of gene expression and regulation.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with genetic disorders or diseases caused by transcriptional defects.
Not a fit: Patients with conditions unrelated to transcriptional mechanisms or those not affected by genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of gene regulation, potentially leading to new therapeutic strategies for diseases linked to transcriptional dysregulation.
How similar studies have performed: Other research has shown success in understanding transcription mechanisms in model organisms, indicating that this approach is built on established scientific foundations.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kaplan, Craig — University of Pittsburgh at Pittsburgh
- Study coordinator: Kaplan, Craig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.